These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 2041267)
1. [Therapeutic efficacy of testolactone (aromatase inhibitor) to oligozoospermia with high estradiol/testosterone ratio]. Itoh N; Kumamoto Y; Maruta H; Tsukamoto T; Takagi Y; Mikuma N; Nanbu A; Tachiki H Nihon Hinyokika Gakkai Zasshi; 1991 Feb; 82(2):204-9. PubMed ID: 2041267 [TBL] [Abstract][Full Text] [Related]
2. Treatment of men with idiopathic oligozoospermic infertility using the aromatase inhibitor, testolactone. Results of a double-blinded, randomized, placebo-controlled trial with crossover. Clark RV; Sherins RJ J Androl; 1989; 10(3):240-7. PubMed ID: 2663800 [TBL] [Abstract][Full Text] [Related]
3. [Long-term therapy of oligozoospermia with the aromatase inhibitor testolactone]. Schill WB; Reiter F; Korting HC; Schweikert HU Hautarzt; 1987 Jul; 38(7):395-9. PubMed ID: 3115914 [TBL] [Abstract][Full Text] [Related]
4. Effect of chronic aromatase inhibition by delta 1-testolactone on pituitary-gonadal function in oligozoospermic men. Dony JM; Smals AG; Rolland R; Fauser BC; Thomas CM Andrologia; 1986; 18(1):69-78. PubMed ID: 3082244 [TBL] [Abstract][Full Text] [Related]
6. Effects of delta 1-testolactone on the pituitary-testicular axis in oligospermic men. Vigersky RA; Glass AR J Clin Endocrinol Metab; 1981 May; 52(5):897-902. PubMed ID: 6785292 [TBL] [Abstract][Full Text] [Related]
7. Effect of aromatase inhibition by delta 1-testolactone on basal and luteinizing hormone-releasing hormone-stimulated pituitary and gonadal hormonal function in oligospermic men. Dony JM; Smals AG; Rolland R; Fauser BC; Thomas CM Fertil Steril; 1985 May; 43(5):787-92. PubMed ID: 3922803 [TBL] [Abstract][Full Text] [Related]
8. [Studies on the production rate of estradiol in the testis in male infertility--studies of the predictive values on therapeutic efficacy in patients with oligozoospermia]. Itoh N; Kumamoto Y; Maruta H Nihon Naibunpi Gakkai Zasshi; 1992 Dec; 68(12):1276-93. PubMed ID: 1291339 [TBL] [Abstract][Full Text] [Related]
9. Outcomes of anastrozole in oligozoospermic hypoandrogenic subfertile men. Shoshany O; Abhyankar N; Mufarreh N; Daniel G; Niederberger C Fertil Steril; 2017 Mar; 107(3):589-594. PubMed ID: 28069178 [TBL] [Abstract][Full Text] [Related]
10. Tamoxifen and testolactone in therapy of oligozoospermia: results of a randomized study. Maier U; Hienert G Eur Urol; 1988; 14(6):447-9. PubMed ID: 3141194 [TBL] [Abstract][Full Text] [Related]
11. Do men with normal testosterone-oestradiol ratios benefit from letrozole for the treatment of male infertility? Shuling L; Sie Kuei ML; Saffari SE; Jiayun Z; Yeun TT; Leng JPW; Viardot-Foucault V; Nadarajah S; Chan JKY; Hao TH Reprod Biomed Online; 2019 Jan; 38(1):39-45. PubMed ID: 30449700 [TBL] [Abstract][Full Text] [Related]
12. Aromatase inhibition by delta 1-testolactone does not relieve the gonadotropin-induced late steroidogenic block in normal men. Smals AG; Dony JM; Smals AE; Pieters GF; Hermus AR; Boers GH; Benraad TJ; Kloppenborg PW J Clin Endocrinol Metab; 1985 Jun; 60(6):1127-31. PubMed ID: 3923019 [TBL] [Abstract][Full Text] [Related]
13. Evidence of a treatable endocrinopathy in infertile men. Pavlovich CP; King P; Goldstein M; Schlegel PN J Urol; 2001 Mar; 165(3):837-41. PubMed ID: 11176482 [TBL] [Abstract][Full Text] [Related]
14. Reversal of the hypogonadotropic hypogonadism of obese men by administration of the aromatase inhibitor testolactone. Zumoff B; Miller LK; Strain GW Metabolism; 2003 Sep; 52(9):1126-8. PubMed ID: 14506617 [TBL] [Abstract][Full Text] [Related]
15. Testosterone versus testosterone and testolactone in treating reproductive and sexual dysfunction in men with epilepsy and hypogonadism. Herzog AG; Klein P; Jacobs AR Neurology; 1998 Mar; 50(3):782-4. PubMed ID: 9521275 [TBL] [Abstract][Full Text] [Related]
16. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations. Wallace EM; Gow SM; Wu FC J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955 [TBL] [Abstract][Full Text] [Related]
17. The effect of testosterone aromatization on high-density lipoprotein cholesterol level and postheparin lipolytic activity. Zmuda JM; Fahrenbach MC; Younkin BT; Bausserman LL; Terry RB; Catlin DH; Thompson PD Metabolism; 1993 Apr; 42(4):446-50. PubMed ID: 8487666 [TBL] [Abstract][Full Text] [Related]
18. Improvement in spermatogenic function after subcutaneous implantation of a capsule containing an aromatase inhibitor in four oligozoospermic dogs and one azoospermic dog with high plasma estradiol-17beta concentrations. Kawakami E; Hirano T; Hori T; Tsutsui T Theriogenology; 2004 Jul; 62(1-2):165-78. PubMed ID: 15159111 [TBL] [Abstract][Full Text] [Related]
19. Effects of the aromatase inhibitor testolactone on human benign prostatic hyperplasia. Schweikert HU; Tunn UW Steroids; 1987; 50(1-3):191-200. PubMed ID: 2460975 [TBL] [Abstract][Full Text] [Related]
20. Role of testosterone/estradiol ratio in predicting the efficacy of tamoxifen citrate treatment in idiopathic oligoasthenoteratozoospermic men. Cakan M; Aldemir M; Topcuoglu M; Altuğ U Urol Int; 2009; 83(4):446-51. PubMed ID: 19996653 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]